• Mashup Score: 12

    This Viewpoint examines the data and circumstances behind the US Food and Drug Administration approval of sunitinib as adjuvant treatment for patients with resected renal cell carcinoma who are at a high risk of relapse.

    Tweet Tweets with this article
    • This is a very positive step towards addressing regulatory capture. https://t.co/540NYOeIqB https://t.co/CyfFJDqMuK https://t.co/RcQTg1oyaT

  • Mashup Score: 2

    February 16 2025-60th Anniversary of Canada’s Flag & Rethinking Cancer Drug Trials Were you flying our flag this weekend? February 15th marked the 60th anniversary of the red and white Maple Leaf and with Donald Trump’s continuing threats against our sovereignty and economy, Flag Day took on a special meaning. I talked with Historica Canada’s Anthony Wilson-Smith about the history of the flag that was first raised on Parliament Hill in 1965. And It seems obvious that new cancer drugs and the clinical trials that test them should put the needs of cancer patients first but according to a group of oncologists, in the last decade, many new treatments have had very small benefits. They have laid out the principles for improving cancer trial design in the influential online journal The Lancet Oncology. I reached Dr. Bishal Gyawali in Kingston.

    Tweet Tweets with this article
    • I had the pleasure of speaking with @ZoomerWeek about @csoncol principles for cancer clinical trials recently published in @TheLancetOncol . Starts at 11:30. https://t.co/8HA0mcLweD

  • Mashup Score: 11

    This Viewpoint examines the data and circumstances behind the US Food and Drug Administration approval of sunitinib as adjuvant treatment for patients with resected renal cell carcinoma who are at a high risk of relapse.

    Tweet Tweets with this article
    • This is a very positive step towards addressing regulatory capture. https://t.co/540NYOeIqB https://t.co/CyfFJDqMuK https://t.co/RcQTg1oyaT

  • Mashup Score: 49

    Top Ten US Cancer Centers make screening recommendations inconsistent with those of the USPSTF recommendations, with cancer centers generally recommending more screening and omitting a nuanced discussion of benefits and risks. Given the national and international reputation of these cancer centers, their recommendations can have important population level implications, including confusion in the public.

    Tweet Tweets with this article
    • The recommendations from Top Cancer Centers is mostly aligned with that of USPSTF for lung cancer but the story is completely different for prostate cancer. Why do you think that is? https://t.co/RlzEuUVIoQ https://t.co/rVIICGvxnB

  • Mashup Score: 1

    Top Ten US Cancer Centers make screening recommendations inconsistent with those of the USPSTF recommendations, with cancer centers generally recommending more screening and omitting a nuanced discussion of benefits and risks. Given the national and international reputation of these cancer centers, their recommendations can have important population level implications, including confusion in the public.

    Tweet Tweets with this article
    • The recommendations from Top Cancer Centers is mostly aligned with that of USPSTF for lung cancer but the story is completely different for prostate cancer. Why do you think that is? https://t.co/RlzEuUVIoQ https://t.co/rVIICGvxnB